Evidence map›Paper›PMID 29229976›Full record

ArticleScientific reports2017

A novel Tn1696-like composite transposon (Tn6404) harboring bla

Kai Zhou, Wei Yu, Ping Shen, Haifeng Lu, Baohong Wang, John W A Rossen, Yonghong Xiao

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Clonal dissemination of carbapenem-resistant ST477Frontiers in cellular and infection microbiology · 2025
    Article
  2. Review
  3. Article
  4. Emergence of an Extensive Drug ResistantInfection and drug resistance · 2024
    Article
  5. Coexistence ofMicrobiology spectrum · 2022
    Article
  6. Article
  7. Review
  8. Detection of IMP-4 and SFO-1 co-producing ST51Frontiers in cellular and infection microbiology · 2022
    Article
  9. Genomics and Virulence ofMicroorganisms · 2021
    Article
  10. Article
  11. Review
  12. Characterization of an IMP-4-ProducingInfection and drug resistance · 2020
    Article
  13. Comprehensive Genome Analysis of Carbapenem-ResistantAntimicrobial agents and chemotherapy · 2019
    Article
  14. SmallFrontiers in microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kai ZhouState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medicine School, Zhejiang University, Hangzhou, China.
Wei YuState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medicine School, Zhejiang University, Hangzhou, China.
Ping ShenState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medicine School, Zhejiang University, Hangzhou, China.
Haifeng LuState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medicine School, Zhejiang University, Hangzhou, China.
Baohong WangState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medicine School, Zhejiang University, Hangzhou, China.
John W A RossenDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Yonghong XiaoState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medicine School, Zhejiang University, Hangzhou, China. xiaoyonghong@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic determinants of a clinical Klebsiella pneumoniae isolate (KP1814) coproducing IMP-4 and a rare ESBL gene SFO-1 was investigated. KP1814 belongs to a novel sequence type (ST) assigned to ST2270. WGS identified four circular DNA sequences in KP1814, including two multidrug-resistance (MDR) plasmids, one virulence plasmid, and one circular form. The MDR plasmid pKP1814-1 (299.9 Kb) is untypeable, and carries two large mosaic multiresistance regions (MRRs). bla

Indexed as

DNA Transposable ElementsDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesDNA, BacterialHumansKlebsiella InfectionsKlebsiella pneumoniaePlasmidsAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase IMP-4beta-Lactamasesbeta-lactamase SFO-1DNA, BacterialDNA Transposable Elements

Identifiers

PMID29229976
PMCPMC5725488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.